Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Leading Pain Management Specialist Dr. Moshe Lewis Addresses Celebrity Deaths and Drug Use, As Well As, the Recent and Untimely Death of Philip Seymour Hoffman
  • USA - English


News provided by

Publicist

Feb 07, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Dr Moshe
Dr Moshe

Los Angeles, CA (PRWEB) February 07, 2014 -- While many celebrity drug deaths have been the result of either suicide or the use of illegal drugs, a surprising number of stars have died by accident, from medications that can be purchased at the corner pharmacy. Sometimes, it can be hard to distinguish if the celebrity death was a suicide or an accidental overdose, as these events are often unwitnessed. Dr. Moshe Lewis, M.D., M.P.H., a Pain Management Specialist, says people, including celebrities, mistakenly perceive drugs prescribed by a doctor as safer than street drugs. But, a haunting stroll down memory lane reveals that this misperception has often been a deadly mistake. Even low doses of seemingly harmless drugs, can be deadly.

The life and untimely death of Philip Seymour Hoffman illustrated many of these points. In a 2006 interview with CBS, Hoffman revealed that he had suffered from drug and alcohol abuse after graduating from college, and went to rehab for drug and alcohol addiction, recovering at age 22. There are thousands of young people like Mr. Hoffman every day who use substances to deal with the stresses of their lives. Now prescription drug abuse has become more prevalent than illegal street drugs. Mr. Hoffman is reported to have relapsed and to have other prescription medications found by his body in addition to heroin. His death has been classified initially as a drug overdose.

The reasons drug abuse amongst the stars is occurring are thus predictable but nevertheless concerning because they make a bold statement about our pursuit for the so-called "good life." No matter how high the stakes, it's somehow still worth it. Despite rehab or warning signs we live in a "have it your way" society. Many patients figure, if one pill isn't doing the trick, two might. When prescription and illicit drugs are combined the risk of death is increased even more. However, people tend to build tolerance fast and thus mistakenly escalate their doses to dangerous levels all the time.

The dangers of combining drugs, meanwhile, which can include additive effects, are often not always obvious to a person reaching for a number of different bottles. Many celebrities thus unknowingly combine medications that accumulate in their body, and compromise their health more quickly than might be the case if these medications were taken separately. Sometimes, this omission is intentional; often it is not.

According to Dr. Lewis, the general public does these same things all the time, combining street with prescription drugs, seeing multiple prescribers, going to multiple pharmacies, begging and demanding early refills and essentially escalating their dosages way too fast.

When "the show must go on," or "the tour must continue," celebrities who are feeling ill can easily be tempted to reach into their old bag of tricks or medicine collection and take what is there. They don't bother worrying about the risk of death or researching the medication(s) side effects on line. Pills may be in the wrong bottle or mixed together.

Pretty soon, unwary celebrities, like many non-celebrities, are popping pills to wake up and/or others to go to sleep. Undiagnosed depression and anxiety, yes - celebrities get the jitters too - are common reasons doctors prescribe anti-depressants and benzodiazepines to them. Often, these two classes of drugs in particular show up in the coroner's report. The death is often labeled "accidental" when the celebrity did not appear to take a high quantity of medication. Frequently, however, the medication has built up in the system and an underlying pneumonia or other form of compromised health has made these medications more toxic than usual. Just because a medication is prescribed doesn't make it any safer than street drugs.

Dr. Lewis says prescription drugs are sneakier because they deceive the user by working slowly over time to cause a deadly high or a fatal crash. A vulnerable celebrity, like many young people, can easily develop drug dependence after being prescribed an opiate-based pain killer. The pills ease their pain and make them feel good. While buprenorphine which was found in Mr. Hoffman's apartment is not a common drug of abuse, many people use it to minimize withdrawal symptoms.

In young people, after just a short period of time, the body develops a tolerance to opiates and the star will need more to feel the same effect. Opiates, benzodiazepines, anxiety medication, muscle relaxers and antidepressants are extremely difficult to stop taking once the body becomes used to them. This is because the brain has natural receptors which are responsible for levels of pain, energy, and pleasure. These receptors are stimulated by the opiate drugs but eventually die off. The result is that when the drug use is stopped, the celebrity can have an extremely difficult time with an over-sensitivity to pain, extreme loss of motivation, and severe depression.

http://www.moshelewismd.com

ANGEL HOWANSKY, Publicist, +1 (310) 497-0989, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.